Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Main Index

View All
Tablet cutters, Practical Options for Prescribing Gradually Tapering Doses Making Up Smaller Doses of Benzodiazepines and Z-Drugs Practically Tapering Benzodiazepines and Z-Drugs in Practice
Tablets antidepressants, gabapentinoids, benzodiazepines and z-drugs, Practical Options for Prescribing Gradually Tapering Doses
Tapering
Tardive dysphoria Discussing Deprescribing Antidepressants with Patients Adverse Effects of Antidepressants
Temazepam Switching to Longer-Acting Benzodiazepines to Taper Making Up Smaller Doses of Benzodiazepines and Z-Drugs Practically Temazepam
The bends
Time of onset Clinical Aspects of Psychiatric Drug Withdrawal Distinguishing Antidepressant Withdrawal Symptoms from Relapse
Tinnitus Clinical Aspects of Antidepressant Withdrawal Distinguishing Benzodiazepine Withdrawal Symptoms from Return of an Underlying Condition Variety of Withdrawal Symptoms from Benzodiazepines and Z-Drugs Discussing Deprescribing Benzodiazepines and Z-Drugs Protracted Benzodiazepine Withdrawal Syndrome When and Why to Stop Benzodiazepines and Z-Drugs
Tranylcypromine
Trazodone Trazodone Practical Options in Prescribing Gradually Tapering Doses of Antidepressants
Triazolam Triazolam Switching to Longer-Acting Benzodiazepines to Taper Withdrawal Symptoms During Benzodiazepine Maintenance Treatment
tricyclic antidepressants (TCA) Adverse Effects of Antidepressants Factors Influencing Development of Withdrawal Effects Recent Developments in the Understanding of Antidepressant Withdrawal Clinical Aspects of Antidepressant Withdrawal Practical Options in Prescribing Gradually Tapering Doses of Antidepressants Stratfiying Risk of Antidepressant Withdrawal
Troubleshooting Further Topics Managing Complications of Antidepressant Discontinuation
The Therapeutics Initiative (TI), Canada